昭衍新药(06127)公布2024年业绩 权益股东应占溢利7407.5万元 同比减少81.3%

智通财经
29 Mar

智通财经APP讯,昭衍新药(06127)公布2024年业绩,收益约20.18亿元,同比减少15.1%;毛利约5.06亿元,同比减少48.4%;公司权益股东应占年内溢利7407.5万元,同比减少81.3%;每股盈利0.1元。在报告期内,公司整体在手订单金额约为22亿元,签署订单金额约为18.4亿元。

公告称,收益减少主要是由于竞争加剧导致项目单位价格下滑所驱动。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10